1 min read
Add as a preferred source on Google

Inogen Targets $20 Million in Savings, Projects Q4 Revenue of $65 Million to $68 Million

Inogen expects to reach $10 million in annualized savings before the end of 2026 and projects full-year continuing-operations revenue of $298 million to $301 million.

A portable oxygen concentrator stands in a quiet clinic room / TokenPost.ai
A portable oxygen concentrator stands in a quiet clinic room / TokenPost.ai

Inogen, Inc. is targeting $20 million in annualized cost savings by the end of 2027 while forecasting fourth-quarter revenue of $65 million to $68 million.

The company expects to reach $10 million in annualized savings before 2026 ends. For full-year 2026, it projects continuing-operations revenue of $298 million to $301 million and an adjusted net loss from continuing operations of $7 million to $8 million.

In the third quarter, U.S. sales returned to year-over-year growth, while international sales fell 9%. Management expects overseas weakness to continue into the fourth quarter and U.S. growth to accelerate enough to offset it.

Inogen’s operating cash flow was negative $4.5 million in the third quarter as working capital increased. It ended the quarter with $97.7 million in cash and no debt.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…